The influence of a polychemotherapeutic regimen on the female endocrine control mechanisms in mammary carcinoma patients.

Since chemotherapy was introduced into the treatment of malignant tumours, cytostatically induced amenorrhoea has been repeatedly described as an undesirable endocrine side effect in sexually mature women.